基于 3 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the detailed record of transactions filed by Meisner Lara. Insider active across 2 companies, notably Bicara Therapeutics Inc.. Cumulatively, 12 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €826k. History available since 15 November 2022. The latest transaction was filed on 29 September 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Meisner Lara is Chief Legal Officer at Viridian Therapeutics, Inc.\DE and Bicara Therapeutics Inc. She has 9 filings in total, and across the 9 sampled filings between 2022-11-16 and 2025-03-18, buy volume is EUR 0 and sell volume is EUR 825873. The most common transaction nature is option exercise.